The UMD-DMD France mutations database
Record ID: 1418

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.1615C>Tp.Arg539XHemizygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
CGAArgTGAStopC->TTs

StructureKey Residue (HCD)Pyrimidin doubletCpG
CRD-repeat #2 Yes, coding strandYes

Mutation impact


At the mRNA levelOn restriction map
r.1615c>uNew restriction site(s): none
Lost restriction site(s): Cla I, Dpn I, Dpn II, Mbo I, Sau3A I, Taq I

On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation)
Dp 427cDp 427mDp 427pDp 260Dp 140Dp 116Dp 71
       
Immunofluorescence
dys 1 dys 2 dys 3
 No signal No signal with Revertant fibers No signal
Western Blot
dys 1 dys 2 dys 3
   

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
---236-3-11ProbandMaleFamilialFRANCE

Phenotypic group
 DMD

Comments


symptomatic carriers in the family

Reference


Reference IDPubMed IDReference
10015351422
Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, Cossee M, Philippe C, Monnier N, Bieth E, Recan D, Antoinette Voelckel M, Perelman S, Lambert JC, Malcolm S, Claustres M. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord. 2004, 14(10):650-8.